Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
SpringWorks Therapeutics, Inc.
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Aveni Foundation
Karyopharm Therapeutics Inc
USWM, LLC (dba US WorldMeds)
Rezolute
AVM Biotechnology Inc
Leap Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Gradalis, Inc.
The University of Texas Health Science Center at San Antonio